Global Stem Cell Cartilage Regeneration Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2028
“Global Stem Cell Cartilage Regeneration Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028” is a recent report generated by MarketResearch.biz. The global stem cell cartilage regeneration market report has been segmented on the basis of stem cell type, treatment, end user, and region.
Global Stem Cell Cartilage Regeneration Market: Overview
Stem cell-based therapy is important factor in functional replacement of cartilage regeneration. Stem cells are categorized into three kind of cells namely: hematopoietic stem cell, mesenchymal stem cells, and pluripotent stem cells.
Global Stem Cell Cartilage Regeneration Market: Dynamics
Rising adoption of minimally invasive surgery procedures, owing to its benefits such as lower risk and shorter duration for surgery is a key factor expected to drive growth of stem cell cartilage regeneration market over the forecast period.
In addition, increasing incidence of osteoarthritis among population across the globe, which in turn expected to support rising adoption of stem cell cartilage regeneration therapy. This factor is expected to boost growth of the target market over the forecast period.
Moreover, government initiatives such as government agencies which focusing on some policies in order to increase adoption of stem cell therapies is another factor expected to propel growth of target market over the forecast period.
However, higher treatment cost is a key factor expected to restrain growth of the global stem cell cartilage regeneration market over the forecast period. In addition, lack of skilled professionals to access stem cell sourcing, processing, or delivering these technologies is another factor expected to hamper growth of the target market over the forecast period.
Ongoing trend observed in the target market is increasing prevalence of osteoarthritis among population and rising adoption of minimally invasive surgery procedures which is turn expected to support growth of the global stem cell based cartilage regeneration market over the forecast period.
Increasing development of innovative technologies, products, and research and development (R&D) activities by key players are major factors expected to create potential revenue opportunities for the target market over the forecast period. In addition, increasing strategic partnership, merger, and acquisition activities by manufacturers are some other factors expected to create lucrative opportunities for player operating in the global market.
Global Stem Cell Cartilage Regeneration Market: Segment Analysis
Among the stem cell type segments, the mesenchymal stem cells segment is expected to register highest CAGR in the target market, owing to increasing research and development activities by various research organizations across the globe.
Global Stem Cell Cartilage Regeneration Market: Regional Analysis
The market in North America is expected to dominate in the global stem cell cartilage regeneration market in terms of revenue over the forecast period, owing to presence of key players operating in the target market such as Vericel Corporation, Osiris Therapeutics, among others and innovative stem cell based cartilage regeneration product launches, and development of new technologies across various countries in the region. In addition, rising geriatric population, which is more prone to degenerative disorders such as osteoarthritis across US is another factor expected to boost growth of the target market in this region.
The market in Asia Pacific is expected to register significant growth in terms of revenue over the forecast period, owing to stem cell based cartilage regeneration procedures are conducted by various hospital, specialty care, and clinics across India.
Global Stem Cell Cartilage Regeneration Market Segmentation:
Segmentation by stem cell type:
- Hematopoietic Stem Cells (HSCs)
- Pluripotent Stem Cells (iPSC/ESCs)
- Mesenchymal Stem Cells (MSCs)
Segmentation by treatment:
- Osteochondral Transplant
- Autologous Chondrocyte Implantation
- Stem Cell Injections
Segmentation by end user:
- Hospitals & Clinics
- Ambulatory Surgical Centers
Segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2019 Estimated Year 2020 Forecast Period 2020–2029 Revenue in US$
- Theracell (Laboratories)
- Orthocell Limited
- Xintela AB (publ)
- CellGenix GmbH
- Merck KGaA
- Osiris Therapeutics, Inc.
- BioTissue Technologies GmbH
- Vericel Corporation
- Smith & Nephew plc
- EMD Serono, Inc.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!